BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4958836)

  • 1. A comparison by several techniques of the antibody prepared in various species against the Rauscher murine leukemia virus.
    Fink MA; Cowles CA; Chirigos MA; Messore J
    Natl Cancer Inst Monogr; 1966 Sep; 22():439-47. PubMed ID: 4958836
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative importance of viral and neoantigens in cytotoxic reaction against murine leukaemia cells.
    Cohen MH; Sibal LR; Fink MA
    Immunology; 1974 Jan; 26(1):37-48. PubMed ID: 4367312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Group and type specific antigens of Rauscher viral leukemia].
    Engel'gardt NV; Abelev GI; Ievleva ES
    Vopr Onkol; 1969; 15(10):76-84. PubMed ID: 4984573
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA; Chirigos MA; Chan SP
    Cancer Res; 1969 May; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunodiffusion: detection of a murine leukemia virus (Rauscher).
    Fink MA; Cowles CA
    Science; 1965 Dec; 150(3704):1723-5. PubMed ID: 4955291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic analysis of L strain cells: a new murine leukemia-associated antigen, "L".
    Leclerc JC; Levy JP; Varet B; Oppenheim S; Senik A
    Cancer Res; 1970 Jul; 30(7):2073-9. PubMed ID: 4318470
    [No Abstract]   [Full Text] [Related]  

  • 7. Murine leukemia and its viruses.
    Rich MA
    Natl Cancer Inst Monogr; 1966 Sep; 22():425-37. PubMed ID: 4288565
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralization of sublines of a mouse leukemia virus with murine antibody, as measured by the spleen focus assay.
    Sinkovics JG; Pienta RJ; Fiorentino M; Bertin BA
    Cancer Res; 1967 Jan; 27(1):88-94. PubMed ID: 6020368
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific precipitation of mouse and rat alpha 2-macroglobulin by immune sera directed against murine leukemia viruses.
    Sassen A; Vander Placetse F
    Biomedicine; 1979 Jun; 30(2):117-20. PubMed ID: 89873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An indirect cytotoxicity test with increased sensitivity against the normal and leukaemic transplantation antigens.
    Motta R
    Rev Eur Etud Clin Biol; 1970 May; 15(5):510-4. PubMed ID: 5310725
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological studies on mouse mammary tumors and leukemia.
    Dmochowski L; Williams WC; Swearingen GR; Myers B; Fujinaga S
    Tex Rep Biol Med; 1971; 29(1):41-62. PubMed ID: 4328256
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunodiffusion analysis of mouse leukemia antigens.
    Lezhneva OM
    Bull Exp Biol Med; 1974 Nov; 77(5):547-50. PubMed ID: 4140741
    [No Abstract]   [Full Text] [Related]  

  • 14. Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components.
    Schäfer W; Fischinger PJ; Lange J; Pister L
    Virology; 1972 Jan; 47(1):197-209. PubMed ID: 4333567
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement fixation in conventional and regressing virus-induced murine leukemia.
    Rich MA; Karl S; Clymer R
    J Immunol; 1971 Jun; 106(6):1488-92. PubMed ID: 4326129
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of fetal antigen(s) in mouse leukemia cells.
    Ortaldo JR; Ting CC; Herberman RB
    Cancer Res; 1974 Jun; 34(6):1366-71. PubMed ID: 4545252
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic characterization of sarcomas artificially infected with Graffi leukemia virus. II. Studies on the differentiation between viral and new cellular antigens].
    Pasternak L; Pasternak G
    Arch Geschwulstforsch; 1968; 32(4):301-8. PubMed ID: 4308111
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the neutralization of the oncogenicity of Friend, Moloney, and Rauscher viruses.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1968 May; 28(5):942-6. PubMed ID: 4870883
    [No Abstract]   [Full Text] [Related]  

  • 19. Abelson virus activity in mice and rats neutralized with anti-Rauscher virus serum.
    Cox KO; Keast D
    J Natl Cancer Inst; 1973 Aug; 51(2):671-3. PubMed ID: 4358140
    [No Abstract]   [Full Text] [Related]  

  • 20. The passive immunotherapy of murine leukaemia. I. The production of antisera against leukaemic antigens.
    Motta R
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):161-7. PubMed ID: 4315341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.